To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Voluntary Trading Update for the six months ended 31 December 2019

Release Date: 05/02/2020 08:00
Code(s): ASC     PDF:  
 
Wrap Text
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(?Ascendis Health? or ?the Company?)


VOLUNTARY TRADING UPDATE FOR THE SIX MONTHS ENDED 31 DECEMBER 2019
The board of directors of Ascendis Health (?the Board?) wishes to provide an update to shareholders on the performance of Ascendis Health and its subsidiaries (the ?Group?) for the 6 months ended 31 December 2019 (?the Current Period?) relative to the 6 months ended 31 December 2018 (?the Prior Period?). The expected revenue and normalised earnings before interest, tax, depreciation and amortisation (?EBITDA?) lower and higher ranges for the Current Period are presented below, along with the Prior Period figures and the percentage change between the lower and higher Current Period figures compared to the Prior Period:
REVENUE
Six months ended Six months ended Six months ended % change % change 31 Dec 2019 31 Dec 2019 31 Dec 2018
Lower range Higher range (Restated)1 Lower range Higher range
INTERNATIONAL 2
Remedica (??m) 54.0 56.7 42.8 26% 33% Sun Wave Pharma (??m) 26.0 27.4 20.6 26% 33% Scitec (??m) 37.0 38.9 37.7 (2%) 3% Farmalider (??m) 16.5 17.3 18.1 (9%) (4%) Other (??m) - - 0.5 Total International - ??m 133.5 140.3 119.7 12% 17% Total International - R?m 2 173 2 285 1 958 11% 17% SOUTH AFRICA
Pharma (R?m) 351 369 336 4% 10% Medical (R?m) 683 718 638 7% 13% Consumer Health (R?m) 456 479 491 (7%) (2%) Biosciences (R?m) 211 222 517 (59%) (57%) Animal Health (R?m) 233 245 245 (5%) - Intercompany
(102) (107) (181) elimination (R?m)
Total South Africa (R?m) 1 832 1 926 2 046 (11%) (6%) GROUP (INTERNATIONAL + SOUTH AFRICA) Total Group - R?m 4 005 4 211 4 004 0% 5% Less: Discontinued
(250) (262) (566) (56%) (54%) operations (R?m)
Group ? continuing - R?m 3 755 3 949 3 438 9% 15%
NORMALISED EBITDA3
Six months ended Six months ended Six months ended % change % change 31 Dec 2019 31 Dec 2019 31 Dec 2018
Lower range Higher range (Restated)1 Lower range
Email this JSE Sens Item to a Friend.

Share This Story